{"id": "1346082736084160513", "creation": 1609766107.0, "user_id": "870037900712431624", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Safety &amp; efficacy data: @Pfizer-@BioNTech_Group #vaccine trial published. 43,548 participants from #USA #Brazil #Argentina #SouthAfrica. #Blacks: 9% #Hispanic/#Latino: 10%. Conferred 95% protection against #COVID19 in persons aged 16 yrs or older https://t.co/nlZEkiMxbA #nihCEAL https://t.co/mL5Broz6Lw", "first_save": 1634559108.199414, "hashtags": ["#SAFETY", "#VACCINE", "#USA", "#BRAZIL", "#ARGENTINA", "#SOUTHAFRICA", "#BLACKS", "#HISPANIC", "#LATINO", "#COVID19", "#NIHCEAL"]}